鲍曼不动杆菌医院感染的临床分布及耐药性研究  

Study of clinical distribution and antimicrobial resistance of Acinetobacter baumannii causing nosocomial infections

作　　者：曹芹芹[1] 余连香[1] 汪红萍[1] 

机构地区：[1]黄山市人民医院,安徽黄山245000

出　　处：《中国消毒学杂志》2015年第2期144-145,共2页Chinese Journal of Disinfection

摘　　要：目的研究住院患者鲍曼不动杆菌医院感染的临床分布及耐药性,为提出有效防控策略提供依据。方法通过回顾性分析,对某医院住院患者送检标本分离的鲍曼不动杆菌检验结果进行调查与分析。结果该医院2年时间内,从住院患者送检标本中共分离出鲍曼不动杆菌66株,主要分离自病人痰标本,构成比为81.82%。鲍曼不动杆菌感染标本主要来自重症监护病房,构成比占69.70%。临床分离的鲍曼不动杆菌对阿米卡星和头孢哌酮/舒巴坦尚比较敏感,但对氨苄西林和头孢替坦耐药率达到88.0%~100%。结论该医院鲍曼不动杆菌感染患者主要分布在ICU,痰标本分离率最高,其耐药率呈上升趋势。Objective To understand the distribution and antimicrobial resistance of Acinetobacter baumannii in the hospital and to provide the scientific evidence for the effective prevention and to control strategy of infective diseases. Methods The retrospective analysis was used to investigate and to analyze the isolated Acinetobacter baumannii from the delivered samplings of inpatients in this hospital. Results In the two years,totally 66 strains of Acinetobacter baumannii were collected from samples in hospitalized patients,which were primarily isolated from sputum,with the proportion of 81. 82%. Specimens of Acinetobacter baumannii infection mainly came from ICU,and the proportion accounted for 69. 70%. The samples were relatively sensitive to Amikacin and Cefoperazone / Sulbactam,but the resistance rates to Ampicillin and Cefotiam reached 88. 0% ~ 100%. Conclusion The drug resistance rate of Acinetobacter baumannii has ascending tendency in the hospital. The infection patients are mainly distributed in the ICU,and commonly occur in the sputum samples.

关 键 词：鲍曼不动杆菌 医院感染 临床分布 耐药性 

分 类 号：R379[医药卫生—病原生物学]